tongue cancer
Conditions
Interventions
Placement of intraoral markers, spacer installation, and contrast-enhanced MRI imaging.
Sponsors
Takuya Nagano
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals who have provided written consent to participate in this clinical study. 2. Individuals diagnosed with tongue cancer with a tumor T-factor of T3 or less (limited to untreated individuals). 3. Individuals aged 18 or older years at the time of consent acquisition.
Exclusion criteria
Exclusion criteria: 1. Individuals with apparent abnormalities in the oral cavity and temporomandibular joint (such as stomatitis, tooth mobility, temporomandibular joint disorder, uncontrolled pain, etc.). 2. Individuals with difficulty breathing through the nose while the mouth is closed (such as nasal congestion, Eustachian tube obstruction, etc.). 3. Individuals with claustrophobia or fear of dark places. 4. Individuals with symptoms of involuntary movements such as tremors. 5. Individuals with severe comorbidities or a history of serious illnesses. 6. Individuals with impaired renal function (GFR 30 or below). 7. Individuals with a history of severe hypersensitivity to components such as resin, acrylic ester, olive oil, blue dye, Aron Alpha A, contrast agents (Magnascope), or Cotton-like wound dressing and protective material(Ora-Aid). 8. Pregnant women or those who might be pregnant. 9. Other individuals deemed inappropriate for participation in this study by the principal investigator (such as those with cognitive impairment or involuntary movements like tremors).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Marker visibility, spacer's tongue fixation performance. | — |
Secondary
| Measure | Time frame |
|---|---|
| Marker adhesion and shape retention properties, suction pressure used for fixation, tolerability, incidence of adverse events, clarity of tumor margins. | — |
Contacts
Public ContactHaraguchi Mihoko
Institute of Science Tokyo Hospital
Outcome results
None listed